Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

1.

[B cell abnormality in systemic lupus erythematosus].

Kitagori K, Kawabata D.

Nihon Rinsho Meneki Gakkai Kaishi. 2012;35(6):495-502. Review. Japanese.

PMID:
23291484
[PubMed - indexed for MEDLINE]
Free Article
2.

Translational Mini-Review Series on B cell subsets in disease. Transitional B cells in systemic lupus erythematosus and Sjögren's syndrome: clinical implications and effects of B cell-targeted therapies.

Vossenkämper A, Lutalo PM, Spencer J.

Clin Exp Immunol. 2012 Jan;167(1):7-14. doi: 10.1111/j.1365-2249.2011.04460.x. Review.

PMID:
22132879
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

B-cell-targeted therapy for systemic lupus erythematosus.

Sabahi R, Anolik JH.

Drugs. 2006;66(15):1933-48.

PMID:
17100405
[PubMed - indexed for MEDLINE]
4.

B-cell-targeted therapies in systemic lupus erythematosus and ANCA-associated vasculitis: current progress.

Md Yusof MY, Vital EM, Emery P.

Expert Rev Clin Immunol. 2013 Aug;9(8):761-72. doi: 10.1586/1744666X.2013.816479. Review.

PMID:
23971754
[PubMed - indexed for MEDLINE]
5.

B-cell targeted therapies in systemic lupus erythematosus: successes and challenges.

Harvey PR, Gordon C.

BioDrugs. 2013 Apr;27(2):85-95. doi: 10.1007/s40259-013-0015-8.

PMID:
23456653
[PubMed - indexed for MEDLINE]
6.

Novel biological treatments for systemic lupus erythematosus: current and future modalities.

Bezalel S, Asher I, Elbirt D, Sthoeger ZM.

Isr Med Assoc J. 2012 Aug;14(8):508-14. Review.

PMID:
22977972
[PubMed - indexed for MEDLINE]
Free Article
7.

[Recombinant proteins or monoclonal antibodies: comparative properties and interest in systemic lupus erythematosus].

Terrier B, Mouthon L.

Med Sci (Paris). 2013 Jan;29(1):65-73. doi: 10.1051/medsci/2013291015. Epub 2013 Jan 25. Review. French.

PMID:
23351696
[PubMed - indexed for MEDLINE]
Free Article
8.

[B-lymphocytes as effectors and regulators in systemic lupus erythematosus].

Winkler TH.

Z Rheumatol. 2014 May;73(4):360-2. doi: 10.1007/s00393-013-1295-6. Review. German. No abstract available.

PMID:
24722870
[PubMed - indexed for MEDLINE]
9.

B-cell-targeted therapy for systemic lupus erythematosus: an update.

Ding C, Foote S, Jones G.

BioDrugs. 2008;22(4):239-49. Review.

PMID:
18611066
[PubMed - indexed for MEDLINE]
10.

B cell elimination in systemic lupus erythematosus.

Furtado J, Isenberg DA.

Clin Immunol. 2013 Feb;146(2):90-103. doi: 10.1016/j.clim.2012.11.006. Epub 2012 Nov 27. Review.

PMID:
23280492
[PubMed - indexed for MEDLINE]
11.

The immunological basis of B-cell therapy in systemic lupus erythematosus.

Mok MY.

Int J Rheum Dis. 2010 Feb 1;13(1):3-11. doi: 10.1111/j.1756-185X.2009.01458.x. Review.

PMID:
20374380
[PubMed - indexed for MEDLINE]
12.

[Progress in B-cell targeting therapy for the treatment of systemic lupus erythematosus].

Tanaka Y.

J UOEH. 2011 Jun 1;33(2):173-81. Review. Japanese.

PMID:
21702122
[PubMed - indexed for MEDLINE]
13.

B cell depletion therapy in systemic lupus erythematosus.

Anolik J, Sanz I, Looney RJ.

Curr Rheumatol Rep. 2003 Oct;5(5):350-6. Review.

PMID:
12967516
[PubMed - indexed for MEDLINE]
14.

Regulators of B-cell activity in SLE: a better target for treatment than B-cell depletion?

Dolff S, Abdulahad WH, Bijl M, Kallenberg CG.

Lupus. 2009 Jun;18(7):575-80. doi: 10.1177/0961203309102296. Review.

PMID:
19433456
[PubMed - indexed for MEDLINE]
15.

B-cell-targeted therapies in systemic lupus erythematosus.

Chan VS, Tsang HH, Tam RC, Lu L, Lau CS.

Cell Mol Immunol. 2013 Mar;10(2):133-42. doi: 10.1038/cmi.2012.64. Epub 2013 Jan 28. Review.

PMID:
23455017
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

[Biological therapies in systemic lupus erythematosus].

Suszek D, Jeleniewicz R, Majdan M.

Postepy Hig Med Dosw (Online). 2012 Aug 22;66:568-73. Review. Polish.

PMID:
22922157
[PubMed - indexed for MEDLINE]
Free Article
17.

[New biological therapy in systemic lupus erythematosus].

Morita K, Fujio K.

Nihon Rinsho. 2012 Nov;70 Suppl 8:539-44. Japanese. No abstract available.

PMID:
23513898
[PubMed - indexed for MEDLINE]
18.

BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus.

Vincent FB, Morand EF, Mackay F.

Immunol Cell Biol. 2012 Mar;90(3):293-303. doi: 10.1038/icb.2011.111. Epub 2012 Jan 10. Review.

PMID:
22231653
[PubMed - indexed for MEDLINE]
19.

Takayasu arteritis is characterised by disturbances of B cell homeostasis and responds to B cell depletion therapy with rituximab.

Hoyer BF, Mumtaz IM, Loddenkemper K, Bruns A, Sengler C, Hermann KG, Maza S, Keitzer R, Burmester GR, Buttgereit F, Radbruch A, Hiepe F.

Ann Rheum Dis. 2012 Jan;71(1):75-9. doi: 10.1136/ard.2011.153007. Epub 2011 Sep 27.

PMID:
21953334
[PubMed - indexed for MEDLINE]
20.

Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus.

Shirota Y, Yarboro C, Fischer R, Pham TH, Lipsky P, Illei GG.

Ann Rheum Dis. 2013 Jan;72(1):118-28. doi: 10.1136/annrheumdis-2012-201310. Epub 2012 Aug 2.

PMID:
22858586
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk